1.
Maji D, Samanta S. A REVIEW ON THE ROLE OF PPARγ AGONISTS AND HYBRIDS IN TYPE 2 DIABETES AND CARDIOMYOPATHY. Asian J Pharm Clin Res [Internet]. 2015 Mar. 1 [cited 2024 Apr. 29];8(2):26-31. Available from: https://journals.innovareacademics.in/index.php/ajpcr/article/view/3993